Lv2
190 积分 2024-03-05 加入
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
2个月前
已完结
Novel antidiabetics for the primary prevention of cardiopulmonary diseases
2个月前
已关闭
Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials
2个月前
已关闭
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
2个月前
已完结
Dapagliflozin improves exercise capacity in HFpEF
2个月前
已完结
Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction
2个月前
已完结
Correction to: The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled trials
2个月前
已关闭
Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adults Running title: Metformin improves sarcopenia-related quality of life
2个月前
已关闭
Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adults Running title: Metformin improves sarcopenia-related quality of life
2个月前
已关闭
Glucagon-Like Peptide-1 Receptor Agonists and Sodium Glucose Cotransporter-2 Inhibitors and Cardiorespiratory Fitness Interaction
2个月前
已关闭
皖公网安备34019202002308
